Clinical trials
Phase 1/2 Pancreatic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
372 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 4 |
| 2004 | 7 |
| 2005 | 6 |
| 2006 | 8 |
| 2007 | 8 |
| 2008 | 10 |
| 2009 | 14 |
| 2010 | 6 |
| 2011 | 7 |
| 2012 | 9 |
| 2013 | 10 |
| 2014 | 8 |
| 2015 | 12 |
| 2016 | 19 |
| 2017 | 22 |
| 2018 | 21 |
| 2019 | 20 |
| 2020 | 17 |
| 2021 | 26 |
| 2022 | 24 |
| 2023 | 21 |
| 2024 | 27 |
| 2025 | 23 |
| 2026 | 28 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 135 |
| Recruiting | 82 |
| Terminated | 51 |
| Unknown status | 37 |
| Active, not recruiting | 26 |
| Withdrawn | 19 |
| Not yet recruiting | 16 |
| Suspended | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 14 |
| Fuda Cancer Hospital, Guangzhou | 6 |
| Eli Lilly and Company | 5 |
| M.D. Anderson Cancer Center | 5 |
| Chinese PLA General Hospital | 4 |
| Gilead Sciences | 4 |
| ImmunityBio, Inc. | 4 |
| Revolution Medicines, Inc. | 4 |
| AstraZeneca | 3 |
| Beijing Biotech | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 372 |
| Colorectal Neoplasms | 74 |
| Carcinoma, Non-Small-Cell Lung | 57 |
| Ovarian Neoplasms | 55 |
| Stomach Neoplasms | 53 |
| Neoplasms | 46 |
| Breast Neoplasms | 44 |
| Neoplasm Metastasis | 43 |
| Colonic Neoplasms | 41 |
| Esophageal Neoplasms | 33 |
Trials
Showing 26 to 50 of 372. Each trial links to its page on Pharma Observatory.
272 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.